What do systematic reviews say?

Coasting vs no coasting

Coasting may leads to lower OHSS compared with no coasting (low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.11 [0.05, 0.24]
  2 studies · 207 participants
  Low

Coasting vs no coasting

It is very uncertain whether coasting changes live birth compared with no coasting (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.48 [0.14, 1.62]
  1 study · 68 participants
  Very low

Coasting vs no coasting

Coasting showed no clear difference in clinical pregnancy compared with no coasting (low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.82 [0.46, 1.44]
  2 studies · 207 participants
  Low

Coasting vs no coasting

Coasting may leads to lower multiple pregnancy compared with no coasting (low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.31 [0.12, 0.81]
  1 study · 139 participants
  Low

Coasting vs no coasting

It is very uncertain whether coasting changes miscarriage compared with no coasting (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.85 [0.25, 2.86]
  2 studies · 207 participants
  Very low

Coasting vs early unilateral follicular aspiration

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs gonadotrophin‐releasing hormone antagonist

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 190 participants
  Very low

Coasting vs gonadotrophin‐releasing hormone antagonist

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs gonadotrophin‐releasing hormone antagonist

Coasting showed no clear difference in clinical Pregnancy compared with gonadotrophin‐releasing hormone antagonist (low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.74 [0.42, 1.31]
  1 study · 190 participants
  Low

Coasting vs gonadotrophin‐releasing hormone antagonist

It is very uncertain whether coasting changes multiple pregnancy compared with gonadotrophin‐releasing hormone antagonist (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.84 [0.39, 1.8]
  1 study · 98 participants
  Very low

Coasting vs gonadotrophin‐releasing hormone antagonist

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs follicle stimulating hormone administration at time of hCG

It is very uncertain whether coasting changes OHSS compared with follicle stimulating hormone administration at time of hCG (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 43.74 [2.54, 754.58]
  1 study · 102 participants
  Very low

Coasting vs follicle stimulating hormone administration at time of hCG

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs follicle stimulating hormone administration at time of hCG

Coasting showed no clear difference in clinical Pregnancy compared with follicle stimulating hormone administration at time of hCG (low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.92 [0.43, 2.01]
  1 study · 102 participants
  Low

Coasting vs follicle stimulating hormone administration at time of hCG

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs follicle stimulating hormone administration at time of hCG

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs cabergoline

It is very uncertain whether coasting changes OHSS compared with cabergoline (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 1.98 [0.69, 5.68]
  2 studies · 120 participants
  Very low

Coasting vs cabergoline

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Coasting vs cabergoline

It is very uncertain whether coasting changes clinical pregnancy rate compared with cabergoline (very low certainty).

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  OR 0.38 [0.16, 0.88]
  2 studies · 120 participants
  Very low

Coasting vs cabergoline

The review found no eligible studies for this question.

• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found